drugset
drugset / Trial / NCT05467709

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

NCT05467709 ↗

Phase 1 Completed 20 enrolled Concert Pharmaceuticals
NaSingle-groupOpen-labelOther

Summary

This is a single center, Phase 1, open-label, fixed-sequence, drug-drug interaction study to determine the effect of CTP-543 on the pharmacokinetics (PK) of midazolam in healthy adult subjects

Timeline

Start
2022-06-21
Primary completion
2022-06-30
Completion
2022-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-543 Unknown 12 mg —
Subject Midazolam Small molecule 2 mg —

Indications

No indication recorded.